Reversal of resistance in multidrug resistance protein (MRP1)-overexpressing cells by LY329146

This publication has 10 references indexed in Scilit:

• Inhibitors of MRP1-mediated multidrug resistance
  Drugs of the Future, 1998
• Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
  New England Journal of Medicine, 1997
• Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAJ) gene in liver
  The FASEB Journal, 1997
• Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP
  Anti-Cancer Drugs, 1997
• Structure−Activity Relationships of Selective Estrogen Receptor Modulators: Modifications to the 2-Arylbenzothiophene Core of Raloxifene
  Journal of Medicinal Chemistry, 1997
• Reconstitution of ATP-dependent Leukotriene C4 Transport by Co-expression of Both Half-molecules of Human Multidrug Resistance Protein in Insect Cells
  Journal of Biological Chemistry, 1996
• ATP-dependent 17β-Estradiol 17-(β-D-Glucuronide) Transport by Multidrug Resistance Protein (MRP)
  Published by Elsevier ,1996
• The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug Resistance
  Biochemical and Biophysical Research Communications, 1995
• Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
  Science, 1992
• Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride (LY 156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity
  Journal of Medicinal Chemistry, 1984